List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 129 studies with search of: Open Studies | "Vomiting"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Unknown  Oral Aprepitant and Lower Dose Dexamethasone Versus Aprepitant Alone for Preventing Postoperative Nausea and Vomiting (PONV) After Elective Laparoscopic Surgeries
Conditions: Nausea;   Vomiting
Interventions: Drug: Dexamethasone;   Drug: Aprepitant;   Drug: Placebo Dexamethasone
2 Unknown  Management of Nausea and Vomiting of Pregnancy
Conditions: Hyperemesis Gravidarum;   Nausea;   Vomiting;   Pregnancy
Interventions: Procedure: Day care;   Procedure: Inpatient
3 Recruiting Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? Formal Study
Conditions: Nausea;   Vomiting
Interventions: Device: Acupressure Wrist Bands (Sea-Bands);   Device: Placebo wristbands
4 Recruiting Fosaprepitant for Breakthrough Chemotherapy Induced Nausea and Vomiting
Conditions: Nausea;   Vomiting
Intervention: Drug: fosaprepitant
5 Recruiting Overnight Use of Electroacustimulation on Postoperative Nausea and Vomiting in the Outpatient Surgery Population
Condition: Post-operative Nausea and Vomiting
Interventions: Device: Battery-operated electroacustimulation device (Inactive);   Device: Battery-operated electroacustimulation device (Active)
6 Recruiting Management of Nausea and Vomiting Chemotherapy-induced in Normandy
Conditions: Cancer;   Nausea;   Vomiting
Intervention:
7 Recruiting Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Palonosetron;   Drug: Ondansetron
8 Recruiting Treatment of Chemotherapy-induced Nausea and Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Aprepitant (Emend);   Drug: Placebo
9 Unknown  Gabapentin in the Prevention of Nausea and Vomiting Induced by Chemotherapy
Conditions: Vomiting;   Cisplatin;   Antineoplastic Combined Chemotherapy Protocols
Interventions: Drug: Placebo;   Drug: Gabapentin
10 Recruiting Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy
Conditions: Nausea;   Vomiting
Interventions: Drug: aprepitant;   Drug: Ondansetron
11 Recruiting Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy
Conditions: Nausea and Vomiting;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: fosaprepitant dimeglumine;   Drug: systemic chemotherapy;   Other: survey administration;   Procedure: quality-of-life assessment
12 Recruiting Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting
Conditions: Breast Cancer;   Malignant Female Reproductive System Neoplasm;   Lymphomas;   Chemotherapy-induced Nausea and Vomiting
Interventions: Behavioral: yoga;   Behavioral: Jacobsons PMRT group
13 Recruiting 10% Carbohydrate Drink for Preventing Post-operative Nausea and Vomiting (PONV) After Spinal Morphine
Condition: Nausea and Vomiting, Postoperative
Interventions: Dietary Supplement: 10% carbohydrate drink;   Other: No intervention
14 Unknown  Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
Conditions: Nausea and Vomiting;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: dexamethasone;   Drug: dronabinol;   Drug: palonosetron hydrochloride;   Other: placebo
15 Recruiting Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Head and Neck Cancer;   Lymphoma;   Nausea and Vomiting;   Neuroblastoma;   Ovarian Cancer;   Sarcoma
Interventions: Procedure: electroacupuncture therapy;   Procedure: management of therapy complications;   Procedure: nausea and vomiting therapy
16 Not yet recruiting A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Rolapitant;   Drug: Granisetron;   Drug: Dexamethasone
17 Not yet recruiting Phase 3 Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Rolapitant;   Drug: Granisetron;   Drug: dexamethasone
18 Recruiting Decreasing the Incidence of Post-Operative Nausea and Vomiting (PONV) in Bariatric Patients
Conditions: Nausea;   Vomiting
Interventions: Drug: Aprepitant;   Drug: Aprepitant placebo
19 Not yet recruiting A Multicenter, Randomized, Double Blind, Active-Controlled Study of the Safety and Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Rolapitant;   Drug: Granisetron;   Drug: Dexamethasone
20 Not yet recruiting Developing Individualized Strategies to Prevent Nausea and Vomiting
Conditions: Postoperative Nausea and Vomiting;   Genetic Polymorphisms
Interventions: Drug: Ondansetron;   Drug: Lorazepam;   Drug: Aprepitant

Previous Page Studies Shown (1-20) Next Page (21-40)
Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options